Insider Buying: Diaceutics PLC (LON:DXRX) Insider Buys £16,067.34 in Stock

Diaceutics PLC (LON:DXRX) insider Graham Paterson bought 11,643 shares of the stock in a transaction that occurred on Thursday, January 30th. The stock was bought at an average price of GBX 138 ($1.70) per share, with a total value of £16,067.34 ($19,741.17).

Diaceutics Stock Down 0.5 %

DXRX opened at GBX 136.25 ($1.67) on Monday. Diaceutics PLC has a 1 year low of GBX 92.24 ($1.13) and a 1 year high of GBX 151 ($1.86). The firm has a 50 day moving average price of GBX 130.24 and a 200 day moving average price of GBX 128.62. The company has a debt-to-equity ratio of 2.93, a quick ratio of 9.92 and a current ratio of 4.85. The company has a market cap of £115.09 million, a PE ratio of -4,541.67 and a beta of 0.58.

Wall Street Analyst Weigh In

DXRX has been the topic of a number of research analyst reports. Canaccord Genuity Group reiterated a “buy” rating and issued a GBX 160 ($1.97) price target on shares of Diaceutics in a report on Tuesday, December 17th. Canaccord Genuity Group reiterated a “buy” rating and issued a GBX 160 ($1.97) target price on shares of Diaceutics in a report on Tuesday, December 17th.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.